These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 9195512
1. Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus. Dayan M, Segal R, Mozes E. J Rheumatol; 1997 Jun; 24(6):1075-82. PubMed ID: 9195512 [Abstract] [Full Text] [Related]
2. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. Segal R, Bermas BL, Dayan M, Kalush F, Shearer GM, Mozes E. J Immunol; 1997 Mar 15; 158(6):3009-16. PubMed ID: 9058840 [Abstract] [Full Text] [Related]
3. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Enghard P, Langnickel D, Riemekasten G. Scand J Rheumatol; 2006 Mar 15; 35(3):209-16. PubMed ID: 16766368 [Abstract] [Full Text] [Related]
4. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Chae BS, Shin TY, Kim DK, Eun JS, Leem JY, Yang JH. Arch Pharm Res; 2008 Apr 15; 31(4):503-10. PubMed ID: 18449509 [Abstract] [Full Text] [Related]
5. Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation. Segal R, Dayan M, Zinger H, Mozes E. Clin Exp Immunol; 1995 Jul 15; 101(1):66-72. PubMed ID: 7621594 [Abstract] [Full Text] [Related]
6. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G. Arthritis Rheum; 1998 May 15; 41(5):838-44. PubMed ID: 9588735 [Abstract] [Full Text] [Related]
7. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice. Alleva DG, Kaser SB, Beller DI. J Immunol; 1997 Dec 01; 159(11):5610-9. PubMed ID: 9548504 [Abstract] [Full Text] [Related]
8. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis. Magari K, Miyata S, Nishigaki F, Ohkubo Y, Mutoh S, Goto T. J Rheumatol; 2003 Oct 01; 30(10):2193-200. PubMed ID: 14528517 [Abstract] [Full Text] [Related]
10. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM. J Rheumatol; 2007 Jan 01; 34(1):89-96. PubMed ID: 17117487 [Abstract] [Full Text] [Related]
12. The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. Sthoeger ZM, Bentwich Z, Zinger H, Mozes E. J Rheumatol; 1994 Dec 01; 21(12):2231-8. PubMed ID: 7699622 [Abstract] [Full Text] [Related]
13. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. Finnegan A, Mikecz K, Tao P, Glant TT. J Immunol; 1999 Nov 15; 163(10):5383-90. PubMed ID: 10553063 [Abstract] [Full Text] [Related]
14. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production. Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He JF, Yang RF, Yun LH. Life Sci; 2007 Oct 27; 81(19-20):1403-10. PubMed ID: 17950363 [Abstract] [Full Text] [Related]
15. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus. Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C. J Pineal Res; 2008 Sep 27; 45(2):204-11. PubMed ID: 18507713 [Abstract] [Full Text] [Related]
19. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. Alleva DG, Kaser SB, Beller DI. J Immunol; 1998 Dec 15; 161(12):6878-84. PubMed ID: 9862720 [Abstract] [Full Text] [Related]